 U.S. officials approved another Alzheimer's drug that can modestly slow the disease. The Food and Drug Administration approved Eli Lilly's Kinsalna for mild or early cases of dementia caused by Alzheimer's. This is the second drug that's shown to delay cognitive decline in patients after the approval of a similar drug last year.